Inorg. Chem. 2006, 45, 8000−8002
Active-Site Models for Iron Hydrogenases: Reduction Chemistry of
Dinuclear Iron Complexes
Inigo Aguirre de Carcer,† Antonio DiPasquale,‡ Arnold L. Rheingold,‡ and D. Michael Heinekey*,†
Department of Chemistry, UniVersity of Washington, Seattle, Washington 98195-1700, and
Department of Chemistry and Biochemistry, UniVersity of California at San Diego,
La Jolla, California 92093-0332
Received June 9, 2006
Reduction of Fe2(
µ
-S2C3H6)(CO)6 (1) in tetrahydrofuran with 1 equiv
Computational studies4 favor the latter possibility in that a
smooth pathway for heterolysis of bound H2 is possible via
proton transfer to the adjacent N atom. More recent crystal-
lographic work is also consistent with this hypothesis.5
Several model systems for this active site based on well-
studied organometallic precursors have been investigated.6
Darensbourg and co-workers reported the crystal structure
of Fe2(µ-S2C3H6)(CO)6 (1) and pointed out its close structural
resemblance to the enzyme active site.7 Rauchfuss and co-
workers have reported that reaction of 1 with CN affords
[Fe2(µ-S2C3H6)(CO)4(CN)2]2-. This dicyano species is readily
oxidized to insoluble materials.8 A very promising Fe2S3
model system that mimics the active site with a pendant
thioether moiety attached to the central C atom of a
propanedithiolate bridging ligand has been reported by
Pickett and co-workers. Interestingly, with this ligand system,
a transient bridging CO species is formed upon reaction with
CN.9 This is a very significant observation because the
existence of a bridging CO ligand in some redox states of
the enzyme has been clearly demonstrated by IR spectros-
copy.2,5 Definitive evidence for bridging CO ligands in model
complexes has been very limited, with the only isolable
complexes being isonitrile10 and cyanide11 derivatives re-
ported by Rauchfuss and co-workers. Interesting model
of decamethylcobaltocene (Cp*2Co) affords a tetranuclear dianion
2. The IR spectra of samples of 2 in solution and in the solid
state exhibit a band at 1736 cm-1, suggestive of the presence of
a bridging carbonyl (CO) ligand. X-ray crystallography confirms
that the structure of 2 consists of two Fe2 units bridged by a
propanedithiolate moiety formulated as [Fe2(
µ-S2C3H6)(CO)5-
(SCH2CH2CH2- -S)Fe2(
µ
µ
-CO)(CO)6]2-. One of the Fe2 units has
a bridging CO ligand and six terminal CO ligands. The second
subunit exhibits a bridging propanedithiolate moiety. One CO ligand
has been replaced by a terminal thiolate ligand, replicating the
basic architecture of Fe-only hydrogenases. The reduction reaction
can be reversed by treatment of 2 with 2 equiv of [Cp2Fe][PF6],
reforming complex 1 in near-quantitative yield. Complex 2 can also
be oxidized by acids such as p-toluenesulfonic acid, regenerating
complex 1 and forming H2.
Recent crystallographic studies of the iron hydrogenase
enzymes1 show that the active site contains a novel Fe2
moiety. Unidentified diatomic ligands were ultimately shown
to be carbonyl (CO) and cyanide (CN) ligands by IR
spectroscopy.2 Activation of H2 is believed to occur at a
vacant site formed by loss of weakly bound water. Inhibition
of enzymatic activity by CO binding to this site has been
demonstrated, and the structure of the CO-bound form has
been determined.3 The proposed dithiolate bridge cannot be
definitively characterized from the crystallographic data on
the enzymes. A propanedithiolate or an azapropanedithiolate
structure with a central N atom has been suggested.
(4) Fan, J.-H.; Hall, M. B. J. Am. Chem. Soc. 2001, 123, 3828-3829.
(5) Nicolet, Y.; de Lacey, A. L.; Vernede, X.; Fernandez, V. M.;
Hatchikian, E. C.; Fonticella-Camps, J. C. J. Am. Chem. Soc. 2001,
123, 1596-1601.
(6) For a summary of early work in this area, cf.: Darensbourg, M. Y.;
Lyon, E. J.; Smee, J. J. Coord. Chem. ReV. 2000, 206, 533-543. For
a more recent review, see: Liu, X.; Ibrahim, S. K.; Tard, C.; Pickett,
C. J. Coord. Chem. ReV. 2005, 249, 1641-1652.
(7) Lyon, E. J.; Georgakaki, I. P.; Reibenspies, J. H.; Darensbourg, M.
Y. Angew. Chem., Int. Ed. 1999, 38, 3178-3179.
(8) Schmidt, M.; Contakes, S. M.; Rauchfuss, T. B. J. Am. Chem. Soc.
1999, 121, 9736-9737.
(9) Le Cloirec, A.; Best, S.; Borg, S.; Davies, S. C.; Evans, D. J.; Hughes,
D. L.; Pickett, C. J. J. Chem. Soc., Chem. Commun. 1999, 2285-
2286. Razavet, M.; Davies, S. C.; Hughes, D. L.; Pickett, C. J. J.
Chem. Soc., Chem. Commun. 2001, 847-848. George, S. J.; Cui, Z.;
Razavet, M.; Pickett, C. J. Chem.sEur. J. 2002, 8, 4037-4046.
(10) Boyke, C. A.; Rauchfuss, T. B.; Wilson, S. R.; Rohmer, M.; Benard,
M. J. Am. Chem. Soc. 2004, 126, 15151-15160.
(11) Boyke, C. A.; van der Vlugt, J. I.; Rauchfuss, T. B.; Wilson, S. R.;
Zampella, G.; De Gioia, L. J. Am. Chem. Soc. 2005, 127, 11010-
11018.
* To whom correspondence should be addressed. E-mail: heinekey@
chem.washington.edu.
† University of Washington.
‡ University of California at San Diego.
(1) Clostridium pasteurianum: Peters, J. W.; Lanzilotta, W. N.; Lemon,
B. J.; Seefeldt, L. C. Science 1998, 282, 1853-1858. DesulfoVibrio
desulfuricans: Nicolet, Y.; Piras, C.; Legrand, P.; Hatchikian, C. E.;
Fontecilla-Camps, J. C. Structure 1999, 7, 13-23.
(2) Pierek, A. J.; Hulstein, M.; Hagen, W. R.; Albracht, S. P. J. Eur. J.
Biochem. 1998, 258, 572-578.
(3) Lemon, B. J.; Peters, J. W. Biochemistry 1999, 38, 12969-12973.
8000 Inorganic Chemistry, Vol. 45, No. 20, 2006
10.1021/ic0610381 CCC: $33.50
© 2006 American Chemical Society
Published on Web 09/01/2006